Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The Journal of Infectious Diseases
|
December 22, 2021
Reply to Anglemyer et al
Florian Zeevat, Cornelis Boersma, Maarten Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 12, 2022
Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults
Florian Zeevat, Jan C Wilschut, Cornelis Boersma, et al.
Vaccine
|
April 17, 2024
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations
Simon van der Pol, Florian Zeevat, Maarten J Postma, et al.
Pharmacoeconomics
|
February 20, 2025
Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection
Florian Zeevat, Simon van der Pol, Alexia Kieffer, et al.
Vaccines
|
February 13, 2021
Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost
Florian Zeevat, Evgeni Dvortsin, Abrham Wondimu, et al.
Advances in Therapy
|
February 10, 2025
Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands
Florian Zeevat, Simon van der Pol, Tjalke Westra, et al.
Vaccine
|
September 28, 2025
Evaluating cost-effectiveness of RSV vaccination strategies for older adults in the Netherlands
Florian Zeevat, Jos Luttjeboer, Koos Korsten, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 12, 2021
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program
Florian Zeevat, Pascal Crépey, F Christiaan K Dolk, et al.
Infectious Diseases and Therapy
|
February 17, 2024
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach
Florian Zeevat, Joost J M Simons, Tjalke A Westra, et al.
Infectious Diseases and Therapy
|
June 26, 2026
Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands
Joost J M Simons, Florian Zeevat, Tjalke A Westra, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The Journal of Infectious Diseases
|
December 22, 2021
Reply to Anglemyer et al
Florian Zeevat, Cornelis Boersma, Maarten Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 12, 2022
Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults
Florian Zeevat, Jan C Wilschut, Cornelis Boersma, et al.
Vaccine
|
April 17, 2024
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations
Simon van der Pol, Florian Zeevat, Maarten J Postma, et al.
Pharmacoeconomics
|
February 20, 2025
Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection
Florian Zeevat, Simon van der Pol, Alexia Kieffer, et al.
Vaccines
|
February 13, 2021
Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost
Florian Zeevat, Evgeni Dvortsin, Abrham Wondimu, et al.
Advances in Therapy
|
February 10, 2025
Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands
Florian Zeevat, Simon van der Pol, Tjalke Westra, et al.
Vaccine
|
September 28, 2025
Evaluating cost-effectiveness of RSV vaccination strategies for older adults in the Netherlands
Florian Zeevat, Jos Luttjeboer, Koos Korsten, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 12, 2021
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program
Florian Zeevat, Pascal Crépey, F Christiaan K Dolk, et al.
Infectious Diseases and Therapy
|
February 17, 2024
Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands-a Holistic Approach
Florian Zeevat, Joost J M Simons, Tjalke A Westra, et al.
Infectious Diseases and Therapy
|
June 26, 2026
Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands
Joost J M Simons, Florian Zeevat, Tjalke A Westra, et al.
Page
of 2